Amphastar Pharmaceuticals (AMPH) EBIT Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) EBIT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 937.04 Mn | 646.91 Mn | 93.47 Mn | 2.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.50% |
| Mar 31, 2026 | -25.85% |
| Dec 31, 2025 | -2.00% |
| Sep 30, 2025 | 2.92% |
| Jun 30, 2025 | 19.33% |
| Mar 31, 2025 | 19.94% |
| Dec 31, 2024 | 23.01% |
| Sep 30, 2024 | 32.06% |
| Jun 30, 2024 | 73.57% |
| Mar 31, 2024 | 67.01% |
| Dec 31, 2023 | 165.66% |
| Sep 30, 2023 | 174.42% |
| Jun 30, 2023 | 144.56% |
| Mar 31, 2023 | 64.72% |
| Dec 31, 2022 | 439.53% |
| Sep 30, 2022 | 112.99% |
| Jun 30, 2022 | 194.38% |
| Mar 31, 2022 | 106.57% |
| Dec 31, 2021 | 150.38% |
| Sep 30, 2021 | 113.36% |